Dendritic cell-cytokine killer combined with microwave ablation reduced recurrence for hepatocellular carcinoma compared to ablation alone
CONCLUSION: Combination therapy with DC-CIK and MWA can significantly reduce the recurrence and prolong DFS, especially for patients ⩽ 60 years old or with moderately-differentiated HCC or co-infected with HBV.PMID:38393935 | DOI:10.3233/THC-230871
Source: Technology and Health Care - Category: Medical Devices Authors: Luo Wang Xin Li Xue-Juan Dong Xiao-Ling Yu Jing Zhang Zhi-Gang Cheng Zhi-Yu Han Fang-Yi Liu Jie Yu Ping Liang Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Health Management | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Immunotherapy | Liver Cancer | Medical Devices | Study